1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 424 F.Supp.3d
  5. 424 F.Supp.3d 355 (2019)
 

EAGLE PHARMACEUTICALS, INC. v. HOSPIRA, INC.

Civil Action No. 18-1074-CFC.

424 F.Supp.3d 355 (2019)

EAGLE PHARMACEUTICALS, INC., Teva Pharmaceuticals International GmbH, and Cephalon, Inc. Plaintiffs, v. HOSPIRA, INC. Defendant.

United States District Court, D. Delaware.

Signed December 18, 2019.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA)
Source: PACER

Attorney(s) appearing for the Case

John Shaw, Karen Keller, Nathan Hoeschen, SHAW KELLER LLP, Wilmington, Delaware; Daniel Brown, Michelle Ernst, LATHAM & WATKINS LLP, New York, New York; Kenneth Schuler, Marc Zubick, LATHAM & WATKINS LLP, Chicago, Illinois; Elise Baumgarten, David Berl, Adam Harber, Shaun Mahaffy, Ben Picozzi, WILLIAMS & CONNOLLY LLP, Washington, District of Columbia, Counsel for Plaintiff.

Arthur Connolly III, Ryan Newell, CONNOLLY GALLAGHER LLP, Wilmington, Delaware; Aaron Barlow, Yusuf Esat, Sara Horton, JENNER & BLOCK LLP, Chicago, Illinois, Counsel for Defendant.

REVISED MEMORANDUM OPINION1

Plaintiffs Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GMBH, and Cephalon, Inc. have sued Defendant Hospira, Inc., alleging infringement of nine patents listed in the Orange Book maintained...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases